Mortality rates and epidemiological changes in critically ill Coronavirus Disease 2019 patients after a vaccination program in Brazil-Reference-Cited by-同舟云学术

Mortality rates and epidemiological changes in critically ill Coronavirus Disease 2019 patients after a vaccination program in Brazil

Published:2022-09-23 Issue: Volume: Page:e20220268
ISSN:1806-3756
Container-title:Jornal Brasileiro de Pneumologia
language:en
Short-container-title:J Bras Pneumol.

Author:

da Silva Braz Junior1 Donato¹^ORCID,Jorge Costa2 Guilherme²^ORCID,Alves de Barros e Lyra3 Nathália³^ORCID,Muniz Arantes Viana3 Mirela³^ORCID,Santos Borba3 Vinícius³^ORCID,Claudio Santos Thuler4,5 Luiz⁴^ORCID,Jorge da Fonseca Lima6 Eduardo⁵^ORCID,Júlia Gonçalves de Mello6 Maria⁵^ORCID

Affiliation:

1. 1. Departamento de Terapia Intensiva, Hospital de Câncer de Pernambuco, Recife (PE), Brasil.

2. 2. Departamento de Ensino e Pesquisa, Hospital de Câncer de Pernambuco, Recife (PE), Brasil.

3. 3. Programa Institucional de Iniciação Científica, Faculdade Pernambucana de Saúde, Recife (PE), Brasil.

4. 4. Instituto Nacional de Câncer, Rio de Janeiro (RJ), Brasil. 5. Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro (RJ), Brasil.

5. 6. Departamento de Pesquisa Clínica, Instituto de Medicina Integral Professor Fernando Figueira, Recife (PE), Brasil.

Publisher

Sociedade Brasileira de Pneumologia e Tisiologia

Reference10 articles.

1. 1. WHO Coronavirus (COVID-19) Dashboard_WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Available from: https://covid19.who.int/.

2. 2. Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Baião F, Hamacher S, et al. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021;9(4):407-418. https://doi.org/10.1016/S2213-2600(20)30560-9.

3. 3. Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel : an observational study using national surveillance data. Lancet. 2021;397(10287):1819–29. https://doi.org/10.1016/S0140-6736(21)00947-8.

4. 4. Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088. https://doi.org/10.1136/bmj.n1088.

5. 5. Zeiser FA, Donida B, da Costa CA, Ramos GO, Scherer JN, Barcellos NT, et al. First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality. Lancet Reg Health Am. 2022;6:100107. https://doi.org/10.1016/j.lana.2021.100107.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for death and illness severity in vaccinated versus unvaccinated COVID-2019 inpatients: a retrospective cohort study;Jornal Brasileiro de Pneumologia;2023-08-11